Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

CD40 ligand gene defects responsible for x-linked hyper-IgM syndrome

Journal Article · · Science (Washington, D.C.); (United States)
; ; ;  [1]; ; ;  [2];  [3]; ; ;  [4]; ;  [5]
  1. Baylor College of Medicine, Houston, TX (United States)
  2. Immunex Research and Development Corp., Seattle, WA (United States)
  3. Univ. of Tennessee, Memphis, TN (United States) St. Jude Children's Research Hospital, Memphis, TN (United States)
  4. National Cancer Inst., Frederick, MD (United States)
  5. Univ. of Washington, Seattle (United States)
The ligand for CD40 (CD40L) is a membrane glycoprotein on activated T cells that induces B cell proliferation and immunoglobulin secretion. Abnormalities in the CD40L gene were associated with an X-linked immunodeficiency in humans [hyper-IgM (immunoglobulin M) syndrome]. This disease is characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. DC40L complementary DNAs from three of four patients with this syndrome contained distinct point mutations. Recombinant expression of two of the mutant CD40L complementary DNAs resulted in proteins incapable of binding to CD40 and unable to induce proliferation of IgE secretion from normal B cells. Activated T cells from the four affected patients failed to express wild-type CD40L, although their B cells responded normally to wild-type CD40L. Thus, these CD40L defects lead to a T cell abnormality that results in the failure of patient B cells to undergo immunoglobulin class switching.
OSTI ID:
6653308
Journal Information:
Science (Washington, D.C.); (United States), Journal Name: Science (Washington, D.C.); (United States) Vol. 259:5097; ISSN SCIEAS; ISSN 0036-8075
Country of Publication:
United States
Language:
English